Free Trial

Evoke (LON:EVOK) Trading Down 18.3% - What's Next?

Evoke logo with Consumer Cyclical background
Remove Ads

Evoke plc (LON:EVOK - Get Free Report) shares fell 18.3% during mid-day trading on Wednesday . The stock traded as low as GBX 56 ($0.72) and last traded at GBX 58.30 ($0.75). 8,720,666 shares were traded during trading, an increase of 322% from the average session volume of 2,066,078 shares. The stock had previously closed at GBX 71.40 ($0.92).

Analyst Ratings Changes

Several research firms have weighed in on EVOK. Berenberg Bank lowered their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating for the company in a research note on Wednesday, December 4th. Jefferies Financial Group reaffirmed a "buy" rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a research report on Monday, December 16th.

Read Our Latest Stock Analysis on EVOK

Evoke Stock Performance

The firm has a market cap of £224.78 million, a P/E ratio of -1.26 and a beta of 0.84. The firm has a fifty day moving average of GBX 68.88 and a 200-day moving average of GBX 63.49.

Evoke (LON:EVOK - Get Free Report) last posted its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Equities research analysts expect that Evoke plc will post 12.7648305 earnings per share for the current year.

Insider Activity at Evoke

In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of Evoke stock in a transaction on Tuesday, January 28th. The stock was bought at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). 27.00% of the stock is currently owned by insiders.

About Evoke

(Get Free Report)

Further Reading

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads